Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar? — Neutral
VTWG Zacks Investment Research — April 04, 2025Designed to provide broad exposure to the Small Cap Growth segment of the US equity market, the Vanguard Russell 2000 Growth ETF (VTWG) is a passively managed exchange traded fund launched on 09/22/2010.
Lucid Posts Y/Y Rise in Q1 Deliveries, Set to Deliver Gravity SUV — Neutral
LCID Zacks Investment Research — April 04, 2025LCID delivers 3,109 vehicles in the first quarter, up 58% year over year and is set to resume deliveries of the Gravity SUV by the end of April.
Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX — Neutral
TMDX Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140931&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 19, 2025 in Zynex, Inc. Lawsuit - ZYXI — Neutral
ZYXI Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=140928&wire=1 or contact Joseph E. Levi, Esq.
Semtech Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 22, 2025 to Discuss Your Rights - SMTC — Neutral
SMTC Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Semtech Corporation (NASDAQ:SMTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semtech-corporation-lawsuit-submission-form?prid=140929&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against Elastic N.V. (ESTC) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
ESTC Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Elastic N.V. (NYSE:ESTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elastic-n-v-lawsuit-submission-form?prid=140933&wire=1 or contact Joseph E.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Fluence Energy Lawsuit - FLNC — Neutral
FLNC Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=140934&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against Neumora Therapeutics, Inc. (NMRA) - April 7, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
NMRA Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=140935&wire=1 or contact Joseph E. Levi, Esq.
Geron Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN — Neutral
GERN Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=140936&wire=1 or contact Joseph E. Levi, Esq.
May 5, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RC — Neutral
RC Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Ready Capital Corporation (NYSE:RC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ready-capital-corporation-lawsuit-submission-form?prid=140949&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Perpetua Resources Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - PPTA — Neutral
PPTA Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=140930&wire=1 or contact Joseph E. Levi, Esq.
APP LAWSUIT ALERT: Levi & Korsinsky Notifies AppLovin Corporation Investors of a Class Action Lawsuit and Upcoming Deadline — Neutral
APP Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=140950&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of an Investigation into Sempra (SRE) Regarding Potential Securities Fraud Allegations — Neutral
SRE Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sempra ("Sempra") (NYSE:SRE) concerning possible violations of federal securities laws. Before the market opened, Sempra released its fourth-quarter and full-year 2024 financial results on February 25, 2025, reporting annual revenue of $3.76 billion-falling $970 million short of consensus estimates.
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA — Neutral
SANA Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=140952&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
NTLA Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=140953&wire=1 or contact Joseph E. Levi, Esq.
Atkore Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 23, 2025 to Discuss Your Rights - ATKR — Neutral
ATKR Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Atkore Inc. (NYSE:ATKR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atkore-inc-lawsuit-submission-form?prid=140951&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Solaris Energy Infrastructure, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SEI — Neutral
SEI Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Solaris Energy Infrastructure, Inc. (NYSE:SEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/solaris-energy-infrastructure-inc-lawsuit-submission-form?prid=140948&wire=1 or contact Joseph E. Levi, Esq.
Lost Money on Venture Global, Inc.(VG)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
VG Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Venture Global, Inc. (NYSE:VG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/venture-global-inc-lawsuit-submission-form?prid=140932&wire=1 or contact Joseph E. Levi, Esq.
Lost Money on Methanex Corporation (MEOH)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky — Neutral
MEOH Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Methanex Corporation ("Methanex Corporation") (NASDAQ:MEOH) concerning possible violations of federal securities laws. Methanex issued a press release on March 9, 2025, "announc[ing].
Lost Money on Supernus Pharmaceuticals, Inc. (SUPN)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky — Neutral
SUPN Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals, Inc.") (NASDAQ:SUPN) concerning possible violations of federal securities laws. On February 19, 2025, The company announced that its Phase 2b study of SPN-820 for treatment-resistant depression failed to meet its primary endpoint, showing no significant improvement over placebo.
